TrialCancer medicine2023

The efficacy and safety of chemo-free therapy in epidermal growth factor receptor tyrosine kinase inhibitor-resistant advanced non-small cell lung cancer: A single-arm, phase II study.

Shuyang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.